Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

350 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ, Kay AC. Kris MG, et al. Among authors: herbst rs. JAMA. 2003 Oct 22;290(16):2149-58. doi: 10.1001/jama.290.16.2149. JAMA. 2003. PMID: 14570950 Clinical Trial.
Chemotherapy for advanced non-small cell lung cancer.
Herbst RS, Dang NH, Skarin AT. Herbst RS, et al. Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7. Hematol Oncol Clin North Am. 1997. PMID: 9209907 Review.
Lung cancer in patients under age 40.
Skarin AT, Herbst RS, Leong TL, Bailey A, Sugarbaker D. Skarin AT, et al. Among authors: herbst rs. Lung Cancer. 2001 Jun;32(3):255-64. doi: 10.1016/s0169-5002(00)00233-6. Lung Cancer. 2001. PMID: 11390007
Emerging therapies in non-small-cell lung cancer.
Khuri FR, Herbst RS, Fossella FV. Khuri FR, et al. Among authors: herbst rs. Ann Oncol. 2001 Jun;12(6):739-44. doi: 10.1023/a:1011197500223. Ann Oncol. 2001. PMID: 11484947 Review.
350 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page